v3.25.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2025
May 01, 2025
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2025  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
Current Fiscal Year End Date --12-31  
Entity Registrant Name INHIBIKASE THERAPEUTICS, INC.  
Entity Central Index Key 0001750149  
Entity Filer Category Non-accelerated Filer  
Entity Shell Company false  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity File Number 001-39676  
Entity Interactive Data Current Yes  
Entity Current Reporting Status Yes  
Entity Tax Identification Number 26-3407249  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 1000 N. West Street  
Entity Address, Address Line Two Suite 1200  
Entity Address, City or Town Wilmington  
Entity Address, State or Province DE  
Entity Address, Postal Zip Code 19801  
City Area Code 302  
Local Phone Number 295-3800  
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol IKT  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   74,341,540